Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX Chemotherapy

التفاصيل البيبلوغرافية
العنوان: Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX Chemotherapy
المؤلفون: M.G. Besselink, F. van der Sijde, Johanna W. Wilmink, Marjolein Y.V. Homs, Dana A. M. Mustafa, J.W.B. de Groot, Eveline E. Vietsch, C.H.J. van Eijck, Brigitte C M Haberkorn, Leonie J. M. Mekenkamp, Saskia A C Luelmo
المصدر: HPB. 23:S681
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Hepatology, business.industry, FOLFIRINOX, medicine.medical_treatment, Gastroenterology, medicine.disease, Tp53 mutation, Internal medicine, Pancreatic cancer, medicine, business
تدمد: 1365-182X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::22b93111b2b3cf86f2f52a9d678933ba
https://doi.org/10.1016/j.hpb.2021.08.025
حقوق: OPEN
رقم الأكسشن: edsair.doi...........22b93111b2b3cf86f2f52a9d678933ba
قاعدة البيانات: OpenAIRE